KRTAP25-1
gene geneOn this page
Also known as KAP25.1
Summary
KRTAP25-1 (keratin associated protein 25-1, HGNC:34003) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 25-1 (Q3LHN0). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to enable structural molecule activity. Predicted to be located in cytosol.
Source: NCBI Gene 100131902 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 16 total
- MANE Select transcript:
NM_001128598
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34003 |
| Approved symbol | KRTAP25-1 |
| Name | keratin associated protein 25-1 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP25.1 |
| Ensembl gene | ENSG00000232263 |
| Ensembl biotype | protein_coding |
| Entrez | 100131902 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000416044
RefSeq mRNA: 1 — MANE Select: NM_001128598
NM_001128598
CCDS: CCDS46640
Canonical transcript exons
ENST00000416044 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001729371 | 30289145 | 30289514 |
Expression profiles
Bgee: expression breadth tissue_specific, 4 present calls, max score 45.85.
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 45.85 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| leukocyte | CL:0000738 | 29.22 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| monocyte | CL:0000576 | 28.42 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| blood | UBERON:0000178 | 25.84 | silver quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| muscle of leg | UBERON:0001383 | 24.74 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| pancreas | UBERON:0001264 | 23.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.99 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (8): KRTAP11-1 (ENSG00000182591), KRTAP13-2 (ENSG00000182816), KRTAP15-1 (ENSG00000186970), KRTAP13-4 (ENSG00000186971), KRTAP26-1 (ENSG00000197683), KRTAP13-1 (ENSG00000198390), KRTAP27-1 (ENSG00000206107), KRTAP13-3 (ENSG00000240432)
Protein
Protein identifiers
Keratin-associated protein 25-1 — Q3LHN0 (reviewed: Q3LHN0)
All UniProt accessions (1): Q3LHN0
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the PMG family.
RefSeq proteins (1): NP_001122070* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007659 | Keratin_matx | Family |
| IPR007951 | KRTAP_PMG | Family |
Pfam: PF05287
UniProt features (2 total): chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LHN0-F1 | 34.60 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 8 (showing top):
chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER
GO Biological Process (0):
GO Molecular Function (1): structural molecule activity (GO:0005198)
GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| molecular_function | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
270 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP25-1 | SCYGR1 | A0A286YEY9 | 791 |
| KRTAP25-1 | KRTAP27-1 | Q3LI81 | 772 |
| KRTAP25-1 | KRTAP24-1 | Q3LI83 | 770 |
| KRTAP25-1 | KRTAP26-1 | Q6PEX3 | 769 |
| KRTAP25-1 | KRTAP22-1 | Q3MIV0 | 582 |
| KRTAP25-1 | KRTAP20-1 | Q3LI63 | 582 |
| KRTAP25-1 | KRTAP6-3 | Q3LI67 | 571 |
| KRTAP25-1 | KRTAP6-2 | Q3LI66 | 570 |
| KRTAP25-1 | KRTAP20-2 | Q3LI61 | 556 |
| KRTAP25-1 | KRTAP13-3 | Q3SY46 | 540 |
| KRTAP25-1 | KRTAP6-1 | Q3LI64 | 507 |
| KRTAP25-1 | KRTAP15-1 | Q3LI76 | 507 |
| KRTAP25-1 | KRTAP21-2 | Q3LI59 | 479 |
| KRTAP25-1 | A8MUN0 | A8MUN0 | 476 |
| KRTAP25-1 | KRTAP5-6 | Q6L8G9 | 431 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A172M4N0, A0A1B0GTH6, A0A1B0GUW6, A1A580, A1YFC1, A1YGK6, A2A5X4, A2T7F2, A4ZUB2, A6NJ88, B2RUR4, C4P6S0, G3X9U1, O48582, P02444, P02445, P02446, P02447, P02449, P02450, P07521, P08335, P20307, P20308, P79958, Q24JX8, Q3LHN0, Q3LI81, Q3LI83, Q3URU2, Q3V0C1, Q3V3Q4, Q5T749, Q5UP52, Q68FV4, Q6AYN3, Q6PEX3, Q6S343, Q7TQM5, Q80Y39
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
16 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 14 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
167 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30289458:A:AC | donor_gain | 0.8400 |
| 21:30289459:C:CC | donor_gain | 0.8400 |
| 21:30289456:C:CT | donor_gain | 0.8100 |
| 21:30289457:T:TT | donor_gain | 0.8100 |
| 21:30289479:T:C | donor_gain | 0.7900 |
| 21:30289470:G:GA | donor_gain | 0.7700 |
| 21:30289167:CA:C | acceptor_gain | 0.7500 |
| 21:30289169:C:CC | acceptor_gain | 0.7500 |
| 21:30289455:A:C | donor_gain | 0.7400 |
| 21:30289460:T:C | donor_gain | 0.7400 |
| 21:30289469:AG:A | donor_gain | 0.7300 |
| 21:30289165:GACA:G | acceptor_gain | 0.7000 |
| 21:30289485:ATG:A | donor_gain | 0.6900 |
| 21:30289331:GATTA:G | donor_loss | 0.6700 |
| 21:30289332:ATTAC:A | donor_loss | 0.6700 |
| 21:30289333:TTAC:T | donor_loss | 0.6700 |
| 21:30289334:TA:T | donor_loss | 0.6700 |
| 21:30289335:A:G | donor_loss | 0.6700 |
| 21:30289336:C:CT | donor_loss | 0.6700 |
| 21:30289467:AAAG:A | donor_gain | 0.6600 |
| 21:30289468:AAG:A | donor_gain | 0.6600 |
| 21:30289337:C:T | donor_loss | 0.6500 |
| 21:30289350:G:C | donor_gain | 0.6500 |
| 21:30289466:AAAAG:A | donor_gain | 0.6200 |
| 21:30289164:AGACA:A | acceptor_gain | 0.6000 |
| 21:30289166:ACAC:A | acceptor_gain | 0.6000 |
| 21:30289487:G:A | donor_gain | 0.6000 |
| 21:30289506:A:C | donor_gain | 0.6000 |
| 21:30289335:A:AC | donor_gain | 0.5900 |
| 21:30289336:C:CC | donor_gain | 0.5900 |
AlphaMissense
690 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30289242:G:C | F83L | 0.772 |
| 21:30289242:G:T | F83L | 0.772 |
| 21:30289244:A:G | F83L | 0.772 |
| 21:30289302:G:C | F63L | 0.717 |
| 21:30289302:G:T | F63L | 0.717 |
| 21:30289304:A:G | F63L | 0.717 |
| 21:30289272:G:C | F73L | 0.672 |
| 21:30289272:G:T | F73L | 0.672 |
| 21:30289274:A:G | F73L | 0.672 |
| 21:30289401:A:C | F30L | 0.624 |
| 21:30289401:A:T | F30L | 0.624 |
| 21:30289403:A:G | F30L | 0.624 |
| 21:30289407:A:C | F28L | 0.621 |
| 21:30289407:A:T | F28L | 0.621 |
| 21:30289409:A:G | F28L | 0.621 |
| 21:30289377:A:C | F38L | 0.616 |
| 21:30289377:A:T | F38L | 0.616 |
| 21:30289379:A:G | F38L | 0.616 |
| 21:30289221:A:C | F90L | 0.598 |
| 21:30289221:A:T | F90L | 0.598 |
| 21:30289223:A:G | F90L | 0.598 |
| 21:30289200:A:C | F97L | 0.571 |
| 21:30289200:A:T | F97L | 0.571 |
| 21:30289202:A:G | F97L | 0.571 |
dbSNP variants (sampled 300 via entrez): RS1000267576 (21:30290935 T>G), RS1002442366 (21:30290494 A>G), RS1002652327 (21:30290789 G>A), RS1003523764 (21:30288905 T>C), RS1005407482 (21:30289811 G>A,T), RS1006278077 (21:30289932 C>G,T), RS1007327994 (21:30291213 G>A), RS1007702986 (21:30291488 G>A), RS1009843266 (21:30290841 C>T), RS1010340261 (21:30291187 C>T), RS1012624269 (21:30288982 G>C), RS1013574411 (21:30290225 C>T), RS1013626682 (21:30290455 C>T), RS1014004782 (21:30288968 A>G), RS1014229514 (21:30290420 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.